Qube Research & Technologies (QRT)
AMLX icon

Qube Research & Technologies (QRT)’s Amylyx Pharmaceuticals AMLX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-15,600
Closed -$44.3K – 3758
2024
Q1 		$44.3K Buy
+15,600
New +$204K ﹤0.01% 3529

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Qube Research & Technologies (QRT)'s AMLX Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Amylyx Pharmaceuticals (AMLX) stake by 70% in Q1 2026, buying an estimated $4.07M and bringing the position to 702,236 shares worth $9.76M. The position accounts for 0.01% of the portfolio, ranked #1298.

Qube Research & Technologies (QRT) first reported a position in AMLX in Q1 2023 and has held it in 13 quarters since. 171 funds tracked by Wall St. Rank hold AMLX as of Q1 2026.

  • Qube Research & Technologies (QRT) held 702,236 shares of Amylyx Pharmaceuticals worth $9.76M as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 289,363 Amylyx Pharmaceuticals shares in Q1 2026, an estimated $4.07M.
  • Amylyx Pharmaceuticals made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #1298 holding.
  • Qube Research & Technologies (QRT) first reported a position in Amylyx Pharmaceuticals in Q1 2023 and has held it in 13 quarters since.
  • 171 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.